Abstract: [7-(3-chloro-4-methoxybenzylamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, is disclosed, as well as a process for its preperation and intermediates in the process of preparing the same.

Abstract: The invention relates to heterocyclic aminoalkylpyridine derivatives of the formula I: where R1 is the radical of a heterocycle having 1 to 3 ring structures, where each ring structure is saturated, unsaturated or aromatic and optionally fused to other ring structures to give a fused ring system and the heterocycle has a total of 1 to 4 N, O and/or S atoms in the ring structures and is optionally monosubstituted, disubstituted or trisubstituted by one or more of the groups -A, —OR4, —N(R4)2, —NO2, —CN, Hal, —COOR4, —CON(R4)2, —COR4, ?O; R2 is a phenyl group which is optionally monosubstituted, disubstituted, trisubstituted, tetrasubstituted or pentasubstituted by one or more of the groups Hal, -A, —O-A, —NO2 or —CN, or is a thienyl group which is optionally monosubstituted or disubstituted by one or more of the groups Hal, -A, —O-A, -NO2, —CN or thienyl; R3 is H, -A, —CO-A, —C(R4)2R2, —C(R4)2-pyridinediyl-R2; R4 is H or -A; A is C1-C6-alkyl, where 1 to 7 hydrogen atoms are optionally replaced by fluor

Abstract: Phospholipase C delta 5 (PLCD5) polypeptides and polynucleotides an methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing phospholipase C delta 5 (PLCD5) polypeptides and polynucleotides in diagnostic assays.

Abstract: Novel phenylcyclohexanes of the formula I in which n is 0 to 7, Q1 and Q2 are H, or one of these radicals is alternatively CH3, r is 0, 1, 2, 3, 4 or 5, A is trans-1,4-cyclohexylene, 1,4-phenylene, 3-fluoro-1,4-phenylene or a single bond, X is F, Cl, —CF3, —CN, —OCF3 or —OCHF2, and Y and Z are each, independently of one another, H or F, with the proviso that, in the case where A is a single bond, Q1=Q2=H and simultaneously X=CN, Y and/or Z are F.

Abstract: An anisotropic polymer film comprising a polymeriZed chiral liquid crystal material with helically twisted structure and having areas with different helical twist sense is useful for decorative or security applications.

Abstract: The invention generally relates to the use of poly-3,3?-dialkyl-2,2?:5?,2?-terthiophenes as charge transport materials or semiconductors in electrooptical, electronic or electroluminescent devices, and to charge transport and semiconducting components and devices comprising poly-3,3?-dialkyl-2,2?:5?,2?-terthiophenes.

Abstract: A liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, which contains: one or more compounds of the general formula I ?in which R, ?Y, Z and n are as defined in claim 1, one or more compounds of the following formulae IIa, IIb, IIc and IId and one or more compounds of the formula in which Ro, Xo, Y2 and r are as defined in claim 1.

Abstract: The invention relates to a lyophilised pharmaceutical preparation comprising an antibody against the endothelial growth factor receptor (EGF receptor). The preparation has increased storage stability, even at elevated temperatures, and, after reconstitution, can be used parenterally for the treatment of tumours.

Abstract: A liquid-crystalline medium having a mixture of polar compounds of positive dielectric anisotropy is described.

Abstract: The invention relates to compounds of the formula I in which R1, R2, R3, R4 and X have the meaning indicated in the text. The compounds act as inhibitors of factors Xa and VIIa and can therefore be employed for the control and prevention of thromboembolic conditions such as thrombosis, myocardial infarct, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and intermittent claudication.

Abstract: The present invention provides Fc-erythropoietin (“Fc-EPO”) fusion proteins with improved pharmacokinetics. Nucleic acids, cells, and methods relating to the production and practice of the invention are also provided.

Abstract: Novel compounds of the formula I in which X, Y, Z, R, R1, R2 and R3 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of tromboembolic diseases and for the treatment of tumors

Abstract: The present invention relates to a novel process for the preparation of bis(trifluoromethyl)imido salts of the general formula (I): [Ma+]?[N(CF3)2]a??(I).

Abstract: The invention relates to a process of preparing disubstituted 9-alkylidenefluorenes and structure analogous compounds, to novel compounds and intermediates prepared by this process, their use for the preparation of conjugated polymers and copolymers thereof, and to novel polymers and copolymers thereby prepared.

Abstract: Described herein are compounds of formula I wherein M1, M2 and M3 have the meanings recited in the disclosure, liquid crystalline mixtures and polymers containing them, and the use of the compounds of formula I, the liquid crystalline mixtures and the polymers containing them in optical and electrooptical devices like liquid crystal displays or projection systems, patterned films and optical elements like polarizers, retardation films, compensators, color filters, holographic elements or polarization beam splitters, for photoswitching, in anisotropic membranes for the permeation of gases or fluids, adhesives, synthetic resins with anisotropic mechanical properties, cosmetic or pharmaceutical compositions, UV absorbers and sunscreens, diagnostics or liquid crystal pigments, for decorative and security applications, in nonlinear optics, optical information storage or as dopants.

Abstract: The invention relates to a novel chromatographic process for the further purification of hydrogen peroxide solutions, giving high-purity solutions which can be employed in semiconductor technology under today's high purity requirements.

Abstract: The invention relates to a liquid crystalline medium characterized by containing one or more compounds of general formula (I) and one or more compounds of formula (II), wherein R1, R2, R3, R4 and c have the meanings as cited in Claim No. 1.

Abstract: An interconnection support for plate-like microcomponents (1) has a support rail (2) which is attached to a support plate (3). An insertion slot (4) for the support rail (2) accommodates an insertion edge (5) of a plate-like microcomponent (1). Like connections (10, 10a), which can be connected to associated connections (11) in an outside (1a) of the plate-like microcomponent (1), are provided in at least one side wall (9) of the insertion slot (4) of the support rail (2).

Abstract: AMLCDs containing a liquid-crystal medium which comprises a) at least one compound of the formula I and b) at least one compound of the formula II where the various parameters are as defined in the text, and to these liquid-crystal media and to their use in electro-optical displays.

Abstract: Liquid-crystalline mediums based on a mixture of polar compounds having positive dielectric aniostropy, characterized in that they comprise one or more compounds of the general formula I in which R, A1, Z1, Y and L are as defined herein, are suitable for use in MLC, TN and STN dispalys.